Jad A Baki1, Elliot B Tapper2,3. 1. Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA. 2. Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA. etapper@umich.edu. 3. Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA. etapper@umich.edu.
Abstract
PURPOSE OF REVIEW: We sought to review the contemporary epidemiology of cirrhosis, focusing on the relative burden of the most common chronic liver diseases. RECENT FINDINGS: The key findings in the review highlight the increasing prevalence and impact of alcohol-related liver disease, particularly among young people, and the epidemic of nonalcoholic fatty liver commensurate with rising rates of obesity. We also contrast recent advances in the care of persons with hepatitis C with the lamentable rise in new infections associated with intravenous drug use. Finally, we highlight the impact of both conventional complications of cirrhosis (namely hepatic encephalopathy) but also the host of patient-reported outcomes adversely impacted by the symptoms of cirrhosis. Cirrhosis is associated with an expanding footprint in contemporary public health. In order to improve global outcomes, we must not only focus on the identifying and treating persons with viral hepatitis but also preventing the rise of alcohol-related liver disease and nonalcoholic fatty liver disease while attending to the urgent patient-centered needs posed by the symptoms of cirrhosis.
PURPOSE OF REVIEW: We sought to review the contemporary epidemiology of cirrhosis, focusing on the relative burden of the most common chronic liver diseases. RECENT FINDINGS: The key findings in the review highlight the increasing prevalence and impact of alcohol-related liver disease, particularly among young people, and the epidemic of nonalcoholic fatty liver commensurate with rising rates of obesity. We also contrast recent advances in the care of persons with hepatitis C with the lamentable rise in new infections associated with intravenous drug use. Finally, we highlight the impact of both conventional complications of cirrhosis (namely hepatic encephalopathy) but also the host of patient-reported outcomes adversely impacted by the symptoms of cirrhosis. Cirrhosis is associated with an expanding footprint in contemporary public health. In order to improve global outcomes, we must not only focus on the identifying and treating persons with viral hepatitis but also preventing the rise of alcohol-related liver disease and nonalcoholic fatty liver disease while attending to the urgent patient-centered needs posed by the symptoms of cirrhosis.
Entities:
Keywords:
Alcohol; Liver disease; Nonalcoholic fatty liver disease; hepatitis C
Authors: G D'Amico; L Pasta; A Morabito; M D'Amico; M Caltagirone; G Malizia; F Tinè; G Giannuoli; M Traina; G Vizzini; F Politi; A Luca; R Virdone; A Licata; L Pagliaro Journal: Aliment Pharmacol Ther Date: 2014-03-24 Impact factor: 8.171
Authors: Steven Scaglione; Stephanie Kliethermes; Guichan Cao; David Shoham; Ramon Durazo; Amy Luke; Michael L Volk Journal: J Clin Gastroenterol Date: 2015-09 Impact factor: 3.062
Authors: Kavish R Patidar; Leroy R Thacker; James B Wade; Richard K Sterling; Arun J Sanyal; Mohammad S Siddiqui; Scott C Matherly; R Todd Stravitz; Puneet Puri; Velimir A Luketic; Michael Fuchs; Melanie B White; Nicole A Noble; Ariel B Unser; HoChong Gilles; Douglas M Heuman; Jasmohan S Bajaj Journal: Am J Gastroenterol Date: 2014-09-02 Impact factor: 10.864
Authors: Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen Journal: JAMA Date: 2012-12-26 Impact factor: 56.272
Authors: Susan L Murphy; James K Richardson; Jennifer Blackwood; Beanna Martinez; Elliot B Tapper Journal: Dig Dis Sci Date: 2020-01-25 Impact factor: 3.199
Authors: Elizabeth S Aby; Adam C Winters; Jonathan Lin; Aileen Bui; Jenna Kawamoto; Matthew B Goetz; Debika Bhattacharya; Joseph R Pisegna; Folasade P May; Arpan A Patel; Jihane N Benhammou Journal: Hepatol Commun Date: 2020-04-24
Authors: Irina V Kholodenko; Leonid K Kurbatov; Roman V Kholodenko; Garik V Manukyan; Konstantin N Yarygin Journal: Cells Date: 2019-09-22 Impact factor: 6.600